These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20515300)

  • 1. Insulin delivery devices--pumps and pens.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S115-6. PubMed ID: 20515300
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus.
    Bolli GB
    J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Documented advantages of insulin Lantus when compared with NPH insulin].
    Frid A
    Lakartidningen; 2004 Sep; 101(39):3014. PubMed ID: 15493644
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin pumps and infusion sets.
    Neithercott T
    Diabetes Forecast; 2011 Jan; 64(1):48-53. PubMed ID: 21337830
    [No Abstract]   [Full Text] [Related]  

  • 5. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
    [No Abstract]   [Full Text] [Related]  

  • 6. Are you up to date on diabetes medications?
    Kestel F
    Am J Nurs; 1994 Jul; 94(7):48-52. PubMed ID: 8017497
    [No Abstract]   [Full Text] [Related]  

  • 7. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pens.
    Gebel E
    Diabetes Forecast; 2011 Jan; 64(1):54-5. PubMed ID: 21337831
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 11. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin therapy in children and adolescents with diabetes.
    Galli-Tsinopoulou A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S114-7. PubMed ID: 21864742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin doses adaptation with insulin Lys-pro in external pump].
    Grimaldi A; Sachon C; Timsit J
    Diabetes Metab; 2001 Jun; 27(3):386-7. PubMed ID: 11431606
    [No Abstract]   [Full Text] [Related]  

  • 17. The journey to metabolic control in diabetes: many more miles to go.
    Silverstein JH; Rosenbloom AL
    J Pediatr; 2003 Dec; 143(6):704-6. PubMed ID: 14657811
    [No Abstract]   [Full Text] [Related]  

  • 18. Selecting an insulin program for type 1 diabetes.
    Scheiner G
    Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
    [No Abstract]   [Full Text] [Related]  

  • 19. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.